GENSET - GENXY Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GENSET - GENXY

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (123)	1/10/2001 4:41:03 PM
From: Mike McFarland	Read Replies (1) of 200

I disagree Nigel, I think this sort of thing is exactly the right move for Genset. We already know that Genset is one of the premium genomics companies--but that now they want to move away from that and increasingly focus on drug development. Anything that streamlines the process is fine with me. It probably makes a lot of sense to subscribe a couple of the biggies, Incyte, Celera, mabye Curagen and such--if only to know what your competitors have access to and run a check on your own work. Maybe it would be arrogant for any biotech company to rely on its own sequencers... Remember, it was not too long ago that Corixa did a deal with Genset to sequence and map the genome of some undisclosed organism, Genset does not have anything to prove in the Genomics area. They do have to prove that they have some targets. Hopefully they will get a chance to do this before Abbott gobbles them up whilst <g> the shares are down and everybody trash-talks the sector. Disclaimer--as of today, I have what I consider to be a 'full position' in Genset. What a great market for buyers. Pure hell for sellers! eom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next